Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

ClinicalTrials.gov ID: NCT00997152

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00997152. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 6:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-controlled, Multi-Center, Parallel Group Study Evaluating the Efficacy, Safety and Pharmacokinetics of JTT-654 Administered for 12 Weeks in Untreated or Metformin-treated Type 2 Diabetic Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of JTT-654 on diabetes as well as the safety, tolerability and pharmacokinetics of JTT-654 in type 2 diabetic patients.

Study identification

NCT ID
NCT00997152
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi Inc.
Industry
Enrollment
152 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Apr 2010 (Actual)
Last update posted
Feb 4, 2013

2009 – 2010

United States locations

U.S. sites
42
U.S. states
17
U.S. cities
42
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Chandler Arizona — —
Not listed Phoenix Arizona — —
Not listed Tempe Arizona — —
Not listed Chino California — —
Not listed Greenbrae California — —
Not listed Huntington Park California — —
Not listed Los Angeles California — —
Not listed Paramount California — —
Not listed Sacramento California — —
Not listed Walnut Creek California — —
Not listed West Covina California — —
Not listed DeLand Florida — —
Not listed Hialeah Florida — —
Not listed Hollywood Florida — —
Not listed Jacksonville Florida — —
Not listed Miami Florida — —
Not listed Port Orange Florida — —
Not listed Marietta Georgia — —
Not listed Addison Illinois — —
Not listed Chicago Illinois — —
Not listed Indianapolis Indiana — —
Not listed Oxon Hill Maryland — —
Not listed New Bedford Massachusetts — —
Not listed Great Falls Montana — —
Not listed Charlotte North Carolina — —
Not listed Morehead City North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Marion Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Lansdale Pennsylvania — —
Not listed Bristol Tennessee — —
Not listed Carrollton Texas — —
Not listed Corpus Christi Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Katy Texas — —
Not listed San Antonio Texas — —
Not listed Sugar Land Texas — —
Not listed Norfolk Virginia — —
Not listed Richmond Virginia — —
Not listed Virginia Beach Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00997152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2013 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.